ArticleSports medicine (Auckland, N.Z.)2026
Adaptation or Maladaptation? Rethinking How Energy Restriction Outcomes Are Monitored.
Article in Sports medicine (Auckland, N.Z.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Energy restriction (ER) serves as both a corrective health measure in metabolically compromised individuals and as a strategically implemented tool to enhance athletic performance and/or meet sporting weight divisions. Individuals with overweight/obesity who embark on a weight loss intervention often experience temporal improvements in metabolic health, only to be undermined by the phenomenon known as adaptive thermogenesis, and subsequent weight regain. ER in elite sport settings, whether a deliberate strategy to manipulate body composition or an unintentional failure to meet the high energy demands of intense training, can also trigger a cascade of adaptive yet energy-conserving measures across biological systems, tissues, and organs, ultimately compromising long-term health. Despite two comparatively different goals, these populations share one common requirement: a sensitive monitoring tool. Predicting problematic ER, however, remains challenging. Contemporary tools employed by practitioners and healthcare providers often suffer from a diagnostic latency, capturing 'whole-body' maladaptations only after they have passed the point of effective corrective input. In this Current Opinion, we propose that metabolomics-the comprehensive analysis of all metabolites in a biological sample-may represent a promising tool to help identify the transition from adaptation to maladaptation by capturing subtle biochemical shifts that precede whole-body changes. We explain how both populations could utilise this tool to identify when ER needs to be corrected to prevent physiological decline and protect long-term health.
Identifiers
42518134What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.